糖尿病足溃疡皮瓣重建的结局:临床研究的系统综述与Meta分析
该系统综述与Meta分析检索截至2022年2月9日的文献,纳入45项研究、1681例接受皮瓣重建的糖尿病足溃疡患者,游离皮瓣最常见(72%)。12个月时死亡率为6.35%(95%CI 3.89%至10.20%),截肢率为11.39%(95%CI 7.02%至17.96%),游离皮瓣失败率为9.95%(95%CI 8.19%至12.05%)。所有研究均存在高偏倚风险,因方法学与结局异质性未进行干预措施的对比Meta分析。
要点
- 12个月死亡率6.35%,截肢率11.39%,游离皮瓣失败率9.95%
- 仅1项研究使用经验证的功能结局测量工具
- 所有纳入研究均为高偏倚风险,缺乏高质量对比研究
核心结论
- 有短期证据表明皮瓣重建(包括显微外科移植)的死亡率、截肢率和皮瓣失败率较低。
- 高质量对比研究有限,皮瓣重建与其他治疗相比的结局仍存在不确定性。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、Embase、Cochrane图书馆和灰色文献,检索日期为2022年2月9日。
- 纳入报告局部、区域或游离皮瓣治疗糖尿病足溃疡结局的对比研究和单臂研究,结局包括功能、肢体丢失、死亡率和皮瓣失败率。
- 共检索到3878条记录,45项研究符合纳入标准,包含1681例接受皮瓣重建的糖尿病足溃疡患者。
- 进行了偏倚风险评估和比例的Meta分析。
主要发现
- 游离皮瓣最常实施(n=1257,72%)。
- 仅1项研究使用了经验证的功能结局测量工具。
- 12个月时死亡率为6.35%(95%CI 3.89%至10.20%)。
- 12个月时肢体丢失率为11.39%(95%CI 7.02%至17.96%)。
- 12个月时游离皮瓣失败率为9.95%(95%CI 8.19%至12.05%)。
关键数值与推荐
- 因研究方法和结局异质性,未进行干预措施的对比Meta分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 所有研究均存在高偏倚风险。
- 因研究方法和结局异质性,未进行干预措施的对比Meta分析。
- 高质量对比研究有限,皮瓣重建与其他治疗相比的结局仍存在不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with diabetic foot ulcers (DFUs) are at risk of major amputation, which is associated with a high mortality rate (exceeding 50% at 5 years) and reduced quality of life. The authors hypothesized that flap reconstruction of DFUs improves patient outcomes in comparison with standard treatment modalities, including major amputation. METHODS: MEDLINE, Embase, the Cochrane Library, and gray literature were searched on February 9, 2022. Comparative and single-arm studies reporting outcomes of DFUs treated with local, regional, or free flaps that included function, limb loss, mortality rates, and flap failure rates were included. Risk of bias was assessed, and meta-analysis of proportions was performed. RESULTS: A total of 3878 records were retrieved, of which 45 met the inclusion criteria, including the records of 1681 patients who underwent flap reconstruction of DFUs. Free flaps were most commonly performed ( n = 1257 [72%]). Only one study used a verified functional outcome measure. At 12 months, the mortality rate was 6.35% (95% CI, 3.89% to 10.20%), the limb loss rate was 11.39% (95% CI, 7.02% to 17.96%), and the free flap failure rate was 9.95% (95% CI, 8.19% to 12.05%). All studies were at high risk of bias. A comparative meta-analysis of interventions was not performed because of study method and outcome heterogeneity. CONCLUSIONS: There is short-term evidence that flap reconstruction (including microsurgical transfer) has low mortality, limb loss, and flap failure rates. However, there are limited high-quality comparative studies, and uncertainty remains regarding the outcome of DFU flap reconstruction in comparison to other treatments.
引用
- Reed AJM, Lim NTY, Yip SWL, et al. Outcomes of Flap Reconstruction for Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis of Clinical Studies. Plast Reconstr Surg. 2023. PMID: 38334716. doi:10.1097/PRS.0000000000011231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。